| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia ES Rosenberg, JM Billingsley, AM Caliendo, SL Boswell, PE Sax, ... Science 278 (5342), 1447-1450, 1997 | 2382 | 1997 |
| HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes KL Collins, BK Chen, SA Kalams, BD Walker, D Baltimore Nature 391 (6665), 397-401, 1998 | 1392 | 1998 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 907 | 2022 |
| The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses SA Kalams, BD Walker The Journal of experimental medicine 188 (12), 2199-2204, 1998 | 844 | 1998 |
| Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection DN Sather, J Armann, LK Ching, A Mavrantoni, G Sellhorn, Z Caldwell, ... Journal of virology 83 (2), 757-769, 2009 | 652 | 2009 |
| Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection SA Kalams, SP Buchbinder, ES Rosenberg, JM Billingsley, DS Colbert, ... Journal of virology 73 (8), 6715-6720, 1999 | 469 | 1999 |
| β-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans L Wagner, OO Yang, EA Garcia-Zepeda, Y Ge, SA Kalams, BD Walker, ... Nature 391 (6670), 908-911, 1998 | 455 | 1998 |
| Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms OO Yang, SA Kalams, A Trocha, H Cao, A Luster, RP Johnson, BD Walker Journal of virology 71 (4), 3120-3128, 1997 | 450 | 1997 |
| Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection T HARRER, E HARRER, SA KALAMS, T ELBEIK, SI STAPRANS, ... AIDS research and human retroviruses 12 (7), 585-592, 1996 | 445 | 1996 |
| Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person … T Harrer, E Harrer, SA Kalams, P Barbosa, A Trocha, RP Johnson, ... Journal of immunology (Baltimore, Md.: 1950) 156 (7), 2616-2623, 1996 | 432 | 1996 |
| Characteristics of the earliest cross-neutralizing antibody response to HIV-1 I Mikell, DN Sather, SA Kalams, M Altfeld, G Alter, L Stamatatos PLoS pathogens 7 (1), e1001251, 2011 | 408 | 2011 |
| Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active … SA Kalams, PJ Goulder, AK Shea, NG Jones, AK Trocha, GS Ogg, ... Journal of virology 73 (8), 6721-6728, 1999 | 369 | 1999 |
| DC-Dielectrophoretic separation of biological cells by size Y Kang, D Li, SA Kalams, JE Eid Biomedical microdevices 10, 243-249, 2008 | 360 | 2008 |
| Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity PO Flores-Villanueva, EJ Yunis, JC Delgado, E Vittinghoff, S Buchbinder, ... Proceedings of the National Academy of Sciences 98 (9), 5140-5145, 2001 | 352 | 2001 |
| Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection PJR Goulder, MA Altfeld, ES Rosenberg, T Nguyen, Y Tang, RL Eldridge, ... The Journal of experimental medicine 193 (2), 181-194, 2001 | 334 | 2001 |
| Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines RI Connor, BTM Korber, BS Graham, BH Hahn, DD Ho, BD Walker, ... Journal of virology 72 (2), 1552-1576, 1998 | 292 | 1998 |
| Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes OO Yang, SA Kalams, M Rosenzweig, A Trocha, N Jones, M Koziel, ... Journal of virology 70 (9), 5799-5806, 1996 | 279 | 1996 |
| Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. SA Kalams, RP Johnson, AK Trocha, MJ Dynan, HS Ngo, RT D'aquila, ... The Journal of experimental medicine 179 (4), 1261-1271, 1994 | 245 | 1994 |
| Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape D Meyer-Olson, NH Shoukry, KW Brady, H Kim, DP Olson, K Hartman, ... The Journal of experimental medicine 200 (3), 307-319, 2004 | 227 | 2004 |
| Lack of strong immune selection pressure by the immunodominant, HLA-A* 0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. C Brander, KE Hartman, AK Trocha, NG Jones, RP Johnson, B Korber, ... The Journal of clinical investigation 101 (11), 2559-2566, 1998 | 203 | 1998 |
